MFN2 and Hyperglycemia: Interestingly, ATP generation was blunted in hyperglycemia-treated cardiomyocytes, but Mfn2 silencing prevented this alteration (Figure 4E), indicating that Mfn2-dependent mitochondria–ER contact impairs mitochondrial ATP production.